A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis

International Journal of Dermatology

Volumn 54, Issue 5, 2015, Pages 509-515

  Stockfleth, Eggert ^a   Peris, Ketty ^b   Guillen, Carlos ^c   Cerio, Rino ^d   Basset Seguin, Nicole ^e   Foley, Peter ^f   Sanches, José ^g   Culshaw, Alex ^h   Erntoft, Sandra ⁱ   Lebwohl, Mark ^j  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h Adelphi International Research   (United Kingdom)

ⁱ Leo Pharma   (Denmark)

^j MOUNT SINAI HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; AWARENESS; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONSENSUS; DELPHI STUDY; DRUG EFFICACY; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL EXPERT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT PARTICIPATION; PHOTOGRAPHY; PHYSICIAN ATTITUDE; PRESCRIPTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TOPICAL TREATMENT; TREATMENT DURATION; CONSENSUS DEVELOPMENT; KERATOSIS, ACTINIC; PRACTICE GUIDELINE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; HUMANS; KERATOSIS, ACTINIC; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC;

EID: 84928365561     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12840     Document Type: Review

References (28)

1. Peris K, Micantonio T, Piccolo D, et al. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges 2007; 5: 970-976.
2. Ackerman AB. Solar keratosis is squamous cell carcinoma. Arch Dermatol 2003; 139: 1216-1217.
3. Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol 2000; 43: 138-150.
4. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; i: 795-797.
5. Mittelbronn MA, Mullins DL, Ramos-Caro FA, et al. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 1998; 37: 677-681.
6. Dinehart SM, Nelson-Adesokan P, Cockerell C, et al. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997; 79: 920-923.
7. Feldman SR, Fleischer AB. Progression of actinic keratosis to squamous cell carcinoma revisited: Clinical and treatment implications. Cutis 2013; 87: 201-207.
8. Czarnecki D, Meehan CJ, Bruce F, et al. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg 2002; 6: 207-209.
9. Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol 1992; 1: 47-51.
10. Lansbury L, Leonardi-Bee J, Perkins W, et al. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010: CD007869.
11. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17.
12. Cohen JL. Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J Clin Aesthet Dermatol 2010; 3: 39-44.
13. Neidecker MV, Davis-Ajami ML, Balkrishnan R, et al. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009; 27: 451-464.
14. Stockfleth E, Ferrandiz C, Grob JJ, et al. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
15. Stockfleth E, Terhorst D, Braathen L, et al. Guideline on Actinic Keratoses (2010). European Dermatology Forum. Available at: www.ensas.ee/www.euroderm.org. Accessed on April 16, 2013.
16. McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. Am Fam Physician 2007; 76: 667-671.
17. van der Geer-Rutten S. Disease Management for Chronic Skin Cancer. PhD Thesis. ISBN 978-94-6169-206-1. Available at: http://download.e-pubs.nl/11/. Accessed on April 16, 2013.
18. Stockfleth E, Kerl H. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606.
19. Murphy MK, Black NA, Lamping DL, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998; 2: 1-88.
20. Akins RB, Tolson H, Cole BR. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 2005; 5: 37.
21. Puig L, Ribera M, Hernanz JM, et al. Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr 2010; 101: 827-846.
22. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
23. Strober B, Berger E, Cather J, et al. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach. J Am Acad Dermatol 2009; 61: S1-S46.
24. Pope E, Lara-Corrales I, Mellerio J, et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012; 67: 904-917.
25. Stockfleth E, Peris K, Guillen C, et al. Physician perceptions and experience of current treatment in actinic keratosis. J Eur Acad Dermatol Venereol 2014. July 27 doi 10.111/jdv.12530 [epub ahead of print]
26. Linstone HA, Turoff M. The Delphi Method: Techniques and Applications. 2002. Available at: http://is.njit.edu/pubs/delphibook/delphibook.pdf. Accessed on April 16, 2013.
27. Tierney EP, Eide MJ, Jacobsen G, et al. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther 2008; 10: 81-86.
28. Berman B, Amini S, Valins W, et al. Pharmacotherapy of actinic keratosis. Expert Opin Pharmacother 2009; 9: S14-S21.